• About
  • Masthead
  • License Content
  • Advertise
  • Press Releases
  • Newsroom
  • RSS/Email List
  • 2MM Podcast
  • Write for us
  • Contact Us
2 Minute Medicine
No Result
View All Result

No products in the cart.

Sign in
SUBSCRIBE
  • About
  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
    • Rewinds
    • The Scan
  • EvidencePulse™
  • HypeCheck™
  • AI News
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Tools
    • NPI Registry Lookup
    • RVU Search
    • Physician Pay by Specialty
    • ICD-10 Code Lookup
    • FDA Drug Approvals
    • Drug Safety for Breastfeeding/Pregnancy
    • Clinical Guidelines
    • Medical Calculators
    • ECG Reference
      • QTc Calculator
      • Sgarbossa Criteria
      • ECG Axis Calculator
      • AV Block Helper
  • Rankings
    • Medical School Rankings
    • Residency Rankings
  • Partners
    • License Content
    • Advertise with Us
2 Minute Medicine
  • About
  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
    • Rewinds
    • The Scan
  • EvidencePulse™
  • HypeCheck™
  • AI News
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Tools
    • NPI Registry Lookup
    • RVU Search
    • Physician Pay by Specialty
    • ICD-10 Code Lookup
    • FDA Drug Approvals
    • Drug Safety for Breastfeeding/Pregnancy
    • Clinical Guidelines
    • Medical Calculators
    • ECG Reference
      • QTc Calculator
      • Sgarbossa Criteria
      • ECG Axis Calculator
      • AV Block Helper
  • Rankings
    • Medical School Rankings
    • Residency Rankings
  • Partners
    • License Content
    • Advertise with Us
Sign in
SUBSCRIBE
2 Minute Medicine
Sign in
Subscribe
2 Minute MedicineFree on Google PlayGet
✦EvidencePulse™by 2 Minute Medicine3 reportsYou askedtop stroke trials 2026Synthesizing medical evidence...Top 2026 stroke trial results:OCEANIC — ischemic stroke: 6.2% vs 8.4%OPTION* — mRS 0–1: 43.6% vs 34.2%ORIENTAL* — mRS 0–2: 58.6% vs 46.6%*Higher sICH in intervention armsParticipants randomizedNOCEANIC12,327OPTION570ORIENTAL564Ask about guidelines or landmark trials...↑Try EvidencePulse™Ask the evidence. Get the signal.Try it now →
Home All Specialties Chronic Disease

Angiotensin receptor blockers may reduce the incidence of epilepsy in patients with hypertension

byGursharan SohiandYuchen Dai
October 24, 2022
in Chronic Disease, Neurology
Reading Time: 3 mins read
Collage for a seizure: an engraved brain crossed by a jagged teal ribbon, a pocket watch and a folded jacket
Share on FacebookShare on TwitterShare on LinkedIn

1. Amongst a cohort of individuals with arterial hypertension, those who were taking angiotensin receptor blocker antihypertensives had the lowest incidence of epilepsy.

2. The highest incidence of epilepsy amongst patients with medication-controlled arterial hypertension was in those taking calcium channel blockers or beta blockers.

Level of Evidence Rating: 2 (Good)

Study Rundown: Epilepsy is a chronic neurological condition characterized by the tendency to experience recurrent seizures. It is a chronic disease which may require lifelong medical therapy and can be refractory to treatment in some cases. In preclinical studies, it has been demonstrated that certain antihypertensive medications may be neuroprotective through modulation of the albumin-induced transforming growth factor cascade pathway in central neurons. Therefore, this study’s purpose was to retrospectively assess the association between epilepsy diagnoses and the treatment of hypertension with various pharmaceutical classes.

In total, 168 612 patients were included, with 42 153 in each subgroup of antihypertensive medication use. The incidence of epilepsy was lowest amongst patients taking ARBs at 1-, 3- and 5-year time points and highest amongst those taking BBs and CCBs. ARBs were significantly reduced with a lower risk of epilepsy; in the analysis of individual drug effects, losartan was significantly protective against epilepsy compared to beta blockers. There was no significant difference in epilepsy incidence based on hypertension severity.

The present study by Doege et al. demonstrated that hypertension management with ARBs may be associated with a decreased risk of epilepsy, particularly in comparison with other classes of antihypertensive, including beta blockers and calcium channel blockers. A strength of this study includes the large sample size and matching of cohorts based on demographics and known risk factors for the outcome. A primary drawback of this work was its retrospective nature, making it difficult to control for confounding. The findings reported here should be studied in a prospective setting to assess their applicability to clinical practice better.

RELATED REPORTS

Carvedilol linked to lower cirrhosis complication risk

Physical frailty is associated with increased risk of epilepsy

Click here to read this study in JAMA Internal Medicine

Relevant reading: Understanding mechanisms of drug resistance in epilepsy and strategies for overcoming it

FDA approvedFor hypertension: Baxfendy (baxdrostat), May 15, 2026→

In-Depth [retrospective cohort]: Data from this study was gleaned through a standardized national database in Germany called the IQVIA, accounting for 3% of outpatient medical practices nationally. Adult patients with a diagnosis of arterial hypertension who were taking one of the following classes of antihypertensives were included: calcium channel blockers (CCBs), beta-blockers (BBs), angiotensin-converting enzyme inhibitors (ACE-i), and angiotensin receptor blockers (ARBs). Propensity scores were assigned based on age, sex, index year and the presence of one of several diagnoses independently associated with epilepsy: diabetes, stroke, Parkinson’s, dementia or mild cognitive impairment and head injuries.

The incidence of epilepsy diagnosis amongst patients taking ARBs was as follows: 0.27% at 1 year, 0.63% at 3 years, and 0.99% at 5 years. The incidence of epilepsy diagnosis amongst patients taking CCBs was 0.38% at 1 year, 0.93% at 3 years, and 1.48% at 5 years. At the same time points, the incidence of epilepsy amongst patients taking BBs was 0.38%, 0.91% and 1.47%, respectively. The hazard ratio for epilepsy risk in patients taking ARBs compared to all other antihypertensives was 0.77 (95% confidence interval 0.65-0.90). The hazard ratio for epilepsy with losartan specifically, compared to BBs, was 0.40 (0.22-0.75) and 0.43 (0.23-0.80) versus CCBs.

Image: PD

©2022 2 Minute Medicine, Inc. All rights reserved. No works may be reproduced without expressed written consent from 2 Minute Medicine, Inc. Inquire about licensing here. No article should be construed as medical advice and is not intended as such by the authors or by 2 Minute Medicine, Inc.

Tags: angiotensin receptor blocker (ARB)angiotensin-converting enzyme inhibitorbeta blockercalcium channel blocker (CCB)epilepsy
Previous Post

Thrombectomy improves functional outcomes for patients with acute stroke due to basilar artery occlusion

Next Post

Post-acute health care burden after SARS-CoV-2 infection

RelatedReports

Cirrhosis collage: an engraved liver with a finely textured surface above lentils, chickpeas and a wedge of cheese
Gastroenterology

Carvedilol linked to lower cirrhosis complication risk

July 6, 2026
Epilepsy and frailty collage: an older woman in a scarf, an engraved brain with teal spark lines, footsteps and a cane
Chronic Disease

Physical frailty is associated with increased risk of epilepsy

May 20, 2026
Transthoracic echocardiography can rule out endocarditis in low-risk bacteremic patients
Weekly Rewinds

2 Minute Medicine Rewind May 18, 2026

May 18, 2026
Brain health collage: an engraved brain in side view, a branching neuron, a plain brain-slice silhouette and a reflex hammer
Neurology

Zorevunersen appears safe and may alleviate symptoms in children with Dravet syndrome

April 2, 2026
Next Post
Novel coronavirus identified from patients with pneumonia in Wuhan, China

Post-acute health care burden after SARS-CoV-2 infection

Group-administered recovery programme may help burn-out, fatigue, and poor sleep

Newborn intensive care collage: a sleeping newborn in a knit cap, swaddled in a white blanket inside an incubator

Organizational factors increase risk of unplanned extubation in neonatal intensive care unit

✦ EvidencePulse™ by 2 Minute Medicine 3 reports You asked top stroke trials 2026 Synthesizing medical evidence... Top 2026 stroke trial results: OCEANIC — ischemic stroke: 6.2% vs 8.4% OPTION* — mRS 0–1: 43.6% vs 34.2% ORIENTAL* — mRS 0–2: 58.6% vs 46.6% *Higher sICH in intervention arms Participants randomizedN OCEANIC 12,327 OPTION 570 ORIENTAL 564 Ask about guidelines or landmark trials... Try EvidencePulse™ Get the signal. Try it now → Physician-trained medical AI by 2 Minute Medicine

2MM+ All Access

Full details →
$4.99 /month

3-day free trial · cancel anytime

  • ✓100+ physician-written reports
  • ✓EvidencePulse™ + HypeCheck™
  • ✓Ad-free reading + newsletters
Start 3-day free trial

Then $4.99/month. Manage renewal in your account.

2 Minute Medicine® is an award winning, physician-run, expert medical media company. Our content is curated, written and edited by practicing health professionals who have clinical and scientific expertise in their field of reporting. Our editorial management team is comprised of highly-trained MD physicians. Join numerous brands, companies, and hospitals who trust our licensed content.

Recent Reports

  • Removing Race and Ethnicity From Dialysis Mortality Risk Adjustment Changes Facility Performance Rankings
  • AI Model Shows Promise in Predicting PTSD Risk Following Trauma
  • 2 Minute Medicine Rewind November 16, 2026
License Content
Terms of Use | Disclaimer
Cookie Policy

Get the app

Read 2 Minute Medicine on iPhone, iPad and Android.

Download on the App StoreGet it on Google Play
QR code for www.2minutemedicine.com/app
On a computer? Scan this with your phone’s camera.
2MM+ All Access Full details →

The medical literature, distilled daily.

Monthly plan selected: $4.99 /month.

$4.99/month

3-day free trial · cancel anytime

Start 3-day free trial

Then $4.99/month. Manage renewal in your account.

Yearly plan selected: $49.90 /year.

$49.90/year

2 months free

Start 3-day free trial

Then $49.90/year.

Membership benefits

  • ✓100+ new physician-written study summaries monthly, 12,000+ searchable
  • ✓AI EvidencePulse™ + HypeCheck™
  • ✓Ad-free reading + newsletters
  • ✓FDA drug approvals + clinical calculators

Already a member? Sign in

  • Get the app
  • About
  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
    • Rewinds
    • The Scan
  • EvidencePulse™
  • HypeCheck™
  • AI News
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Tools
    • NPI Registry Lookup
    • RVU Search
    • Physician Pay by Specialty
    • ICD-10 Code Lookup
    • FDA Drug Approvals
    • Drug Safety for Breastfeeding/Pregnancy
    • Clinical Guidelines
    • Medical Calculators
    • ECG Reference
      • QTc Calculator
      • Sgarbossa Criteria
      • ECG Axis Calculator
      • AV Block Helper
  • Rankings
    • Medical School Rankings
    • Residency Rankings
  • Partners
    • License Content
    • Advertise with Us
No Result
View All Result

© 2026 2 Minute Medicine, Inc. - Physician-written medical news.